Industry Relations and Technology Transfer

Express Licenses

How it Works

Express Licenses: The following monoclonal antibodies are currently available for express licensing through the Fred Hutchinson Cancer Research Center. These agreements have standard terms and conditions that allow for immediate licensing by companies or individuals who wish to pay license fees using a check.

The conditions and financial terms of express licenses apply only to those who complete the express license process online using this website.  If the express license for a specific technology does not meet your needs, other arrangements can be discussed. Should a modification, addition or amendment be discussed, a fee equal to the Signing Fee shall be due to Hutchinson Center with such request.

The Hutchinson Center may have other monoclonal antibodies available through standard licensing. Please contact Kristi Sullivan at ksulliva@fhcrc.org to inquire about antibodies not available through express licensing or check our “Available Technologies” online.

The antibody list is available here online. If you would like to license any of these antibodies, please complete the Hutchinson Center Express License Agreement below. 

Instructions:

Send completed License with License Fee (made payable to Fred Hutchinson Cancer Research Center) to:

Fred Hutchinson Cancer Research Center
Industry Relations & Technology Transfer
Attention: Express Licensing
P.O. Box 19024, J5-110
Seattle, WA 98109-1024

Any modifications to the license terms are subject to the current Agreement Modification Fee of the Hutchinson Center.

Licenses without payment included will be returned to the proposed licensee.

If your company requires a purchase order or other means of payment,
please e-mail mailto: ksulliva@fhcrc.org

Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.